Correlation Between AN2 Therapeutics and Puma Biotechnology
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Puma Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Puma Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Puma Biotechnology, you can compare the effects of market volatilities on AN2 Therapeutics and Puma Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Puma Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Puma Biotechnology.
Diversification Opportunities for AN2 Therapeutics and Puma Biotechnology
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between AN2 and Puma is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Puma Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Puma Biotechnology and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Puma Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Puma Biotechnology has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Puma Biotechnology go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Puma Biotechnology
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 5.87 times less return on investment than Puma Biotechnology. But when comparing it to its historical volatility, AN2 Therapeutics is 1.79 times less risky than Puma Biotechnology. It trades about 0.06 of its potential returns per unit of risk. Puma Biotechnology is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 279.00 in Puma Biotechnology on December 4, 2024 and sell it today you would earn a total of 56.00 from holding Puma Biotechnology or generate 20.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AN2 Therapeutics vs. Puma Biotechnology
Performance |
Timeline |
AN2 Therapeutics |
Puma Biotechnology |
AN2 Therapeutics and Puma Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AN2 Therapeutics and Puma Biotechnology
The main advantage of trading using opposite AN2 Therapeutics and Puma Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Puma Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Puma Biotechnology will offset losses from the drop in Puma Biotechnology's long position.AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Puma Biotechnology vs. Ultragenyx | Puma Biotechnology vs. Crinetics Pharmaceuticals | Puma Biotechnology vs. Arvinas | Puma Biotechnology vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |